REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Clinical trials for REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to tackle lymphoma in communities often left behind
Disease control Recruiting nowThis early-stage trial tests two oral drugs, zanubrutinib and sonrotoclax, for people with B-cell non-Hodgkin lymphoma that has returned or not responded to prior treatment. The study focuses on Black, Hispanic, and other underrepresented groups to improve access and outcomes. Ab…
Matched conditions: REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
New combo therapy aims to beat back tough blood cancers
Disease control Recruiting nowThis study tests whether adding a targeted drug (nemtabrutinib) to a personalized cell therapy (CAR-T) can help people with chronic lymphocytic leukemia or small lymphocytic lymphoma that has returned or stopped responding to treatment. About 20 adults will receive the combinatio…
Matched conditions: REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 19, 2026 12:01 UTC